US2011052563A1PendingUtilityA1
Gonadal function improving agents
Est. expiryMar 12, 2023(expired)· nominal 20-yr term from priority
A61P 5/00A61P 5/08A61P 35/00A61K 38/1709A61K 31/00G01N 33/689A61P 15/00A61P 15/08A61K 31/7088
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Metastin, compounds that promote the activity of metastin or its receptors and the like are excellent gonadal function improving agents, ovulation inducers or promoters, gonadotropic hormone secretion promoters, gonadotropic hormone secretion inhibitors, sex hormone secretion promoters, sex hormone secretion inhibitors, etc., and can be used as agents for preventing/treating sterility, hormone-sensitive cancers, endometriosis, etc. Metastin and its receptors are useful for screening for these pharmaceuticals.
Claims
exact text as granted — not AI-modified1 .- 23 . (canceled)
24 . A method of improving gonadal function, which comprises administering to a mammal an effective dose of (i) a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, (ii) a polynucleotide encoding said polypeptide or a salt thereof, (iii) a compound or its salt that promotes the activity of said polypeptide or a salt thereof, (iv) a compound or its salt that promotes the activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 20, its partial peptide, or a salt thereof, or (v) a compound or its salt that promotes the activation of said polypeptide or a salt thereof into said protein, its partial peptide, or a salt thereof.
25 . A method of improving gonadal function, which comprises (i) promoting the activity of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, (ii) promoting the activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 20, its partial peptide, or a salt thereof, or (iii) promoting the activation of said polypeptide or a salt thereof into said protein, its partial peptide, or a salt thereof.
26 . (canceled)
27 . A method of inhibiting gonadotropic hormone secretion and/or a method of inhibiting sex hormone secretion, which comprises administering to a mammal an effective dose of (i) a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, (ii) a polynucleotide encoding said polypeptide or a salt thereof, (iii) a compound or its salt that promotes the activity of said polypeptide or a salt thereof, (iv) a compound or its salt that promotes the activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 20, its partial peptide, or a salt thereof, or (v) a compound or its salt that promotes the activation of said polypeptide or a salt thereof into said protein, its partial peptide, or a salt thereof.
28 . A method of preventing/treating a hormone-sensitive cancer or endometriosis, which comprises uninterruptedly or continuously administering to a mammal an effective dose of (i) a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, (ii) a polynucleotide encoding said polypeptide or a salt thereof, (iii) a compound or its salt that promotes the activity of said polypeptide or a salt thereof, (iv) a compound or its salt that promotes the activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 20, its partial peptide, or a salt thereof, or (v) a compound or its salt that promotes the activation of said polypeptide or a salt thereof into said protein, its partial peptide, or a salt thereof.
29 . A method of inhibiting follicular maturation and/or a method of suspending a menstrual cycle, which comprises uninterruptedly or continuously administering to a mammal an effective dose of (i) a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, (ii) a polynucleotide encoding said polypeptide or a salt thereof, (iii) a compound or its salt that promotes the activity of said polypeptide or a salt thereof, (iv) a compound or its salt that promotes the activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 20, its partial peptide, or a salt thereof, or (v) a compound or its salt that promotes the activation of said polypeptide or a salt thereof into said protein, its partial peptide, or a salt thereof.
30 . A method of promoting gonadotropic hormone secretion and/or a method of promoting sex hormone secretion, which comprises applying bolus administration to a mammal in an effective dose of (i) a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, (ii) a polynucleotide encoding said polypeptide or a salt thereof, (iii) a compound or its salt that promotes the activity of said polypeptide or a salt thereof, (iv) a compound or its salt that promotes the activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 20, its partial peptide, or a salt thereof, or (v) a compound or its salt that promotes the activation of said polypeptide or a salt thereof into said protein, its partial peptide, or a salt thereof.
31 . A method of inducing or promoting ovulation, which comprises applying bolus administration to a mammal in an effective dose of (i) a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, (ii) a polynucleotide encoding said polypeptide or a salt thereof, (iii) a compound or its salt that promotes the activity of said polypeptide or a salt thereof, (iv) a compound or its salt that promotes the activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 20, its partial peptide, or a salt thereof, or (v) a compound or its salt that promotes the activation of said polypeptide or a salt thereof into said protein, its partial peptide, or a salt thereof.
32 . The method according to claim 27 , wherein the gonadotropic hormone is luteinizing hormone.
33 . The method according to claim 27 , wherein the sex hormone is estrogen or progesterone.
34 . The method according to claim 30 , wherein the gonadotropic hormone is luteinizing hormone.
35 . The method according to claim 30 , wherein the sex hormone is estrogen or progesterone.
36 . The method according to claim 24 , which comprises administering to said mammal an effective dose of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.
37 . The method according to claim 25 , which comprises promoting the activity of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.
38 . The method according to claim 27 , which comprises administering to said mammal an effective dose of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.
39 . The method according to claim 28 , which comprises administering to said mammal an effective dose of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.
40 . The method according to claim 29 , which comprises administering to said mammal an effective dose of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.
41 . The method according to claim 30 , which comprises applying to said mammal an effective dose of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.
42 . The method according to claim 31 , which comprises applying to said mammal an effective dose of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.Join the waitlist — get patent alerts
Track US2011052563A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.